| Effects of long-term coenzyme Q10 and captopril treatment on survival and functional capacity in rats with experimentally induced heart infarction. | |
| | |
MedLine Citation:
|
PMID: 2213566 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The effects of coenzyme Q10 (CoQ) and captopril on functional capacity, hemodynamics and survival were studied in 154 rats that recovered after experimental myocardial infarction. Rats were randomized into four groups receiving either CoQ, captopril, a combination of the two drugs or 1 ml of tap water once daily for 12 weeks from the day of coronary artery ligation. CoQ as well as captopril and the combined treatment significantly improved exercise capacity as evaluated by lactate production during a standardized treadmill exercise test. No significant changes in heart rate or mean blood pressure were observed during the study in the captopril-treated group. CoQ treatment increased the maximum heart rate significantly, whereas no effect on mean blood pressure was observed. Both captopril and CoQ decreased pulmonary congestion. Furthermore, the data may suggest that captopril prevents right ventricular hypertrophy seen in placebo-treated rats with large infarcts. This was not observed after CoQ treatment. Captopril treatment improved 3-month probability of survival (93%) as compared with placebo (74%) (P less than .05). CoQ and the combined treatment tended to improve survival, but this was, however, not statistically significant. |
| | |
Authors:
|
O M Bech; J D Sørensen; M K Jensen; B Diamant; E Steiness |
Related Documents
:
|
2977176 - Atrial natriuretic factor protects the isolated working ischaemic rat heart against the... 18250366 - Cardiac overexpression of angiotensin converting enzyme 2 protects the heart from ische... 9861306 - Pulmonary and cardiac expression of preproendothelin-1 mrna are increased in heart fail... 10758976 - Evaluation of the effects of intramyocardial injection of dna expressing vascular endot... 15056836 - Coronary spastic angina in patients with connective tissue disease. 22613516 - First report of a novel abluminal groove filled biodegradable polymer rapamycin-eluting... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: The Journal of pharmacology and experimental therapeutics Volume: 255 ISSN: 0022-3565 ISO Abbreviation: J. Pharmacol. Exp. Ther. Publication Date: 1990 Oct |
Date Detail:
|
Created Date: 1990-11-21 Completed Date: 1990-11-21 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0376362 Medline TA: J Pharmacol Exp Ther Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 346-50 Citation Subset: IM |
Affiliation:
|
Department of Clinical Pharmacology, University of Aarhus, Denmark. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Body Weight / drug effects Captopril / administration & dosage, pharmacology* Coenzymes Drug Synergism Energy Metabolism / drug effects Female Heart Failure / drug therapy Hemodynamics / drug effects Myocardial Infarction / mortality, physiopathology* Organ Size / drug effects Rats Survival Rate Ubiquinone / administration & dosage, blood, pharmacology* |
| Chemical | |
Reg. No./Substance:
|
0/Coenzymes; 1339-63-5/Ubiquinone; 303-98-0/coenzyme Q10; 62571-86-2/Captopril |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: A patch clamp study of muscarinic excitation of the rat adrenal chromaffin cells.
Next Document: Characterization of the effect of two 4-methyl piperidine derivatives of hemicholinium-3, A-4 and A-...